Sofia Diana Merajver, MD, PhD

Dr. Sofia Merajver received a doctoral degree in physics from the University of Maryland and a medical degree from the University of Michigan. She completed a residency in internal medicine and a fellowship in oncology at the University of Michigan before joining the faculty in 1994. Dr. Merajver, an expert in breast cancer genetics, is the medical director of the Breast and Ovarian Cancer Risk Evaluation Program at the U-M Rogel Cancer Center. Her research interests include the molecular genetics of breast cancer, gene function and cancer risk assessment. She enjoys literature, music and outdoor activities with her family.

Breast Cancer treatment and genetic risk assessment and counseling. Breast and ovarian cancer risk and evaluation, inflammatory breast cancer, angiogenesis, and locally advanced breast cancer.

University of Michigan Health participates with most health insurance plans.

Molecular genetics of breast cancer, BRCA1 gene function, angiogenesis, cancer risk assessment.Please see these links for further information on Dr. Merajver's research: